Skip to main content

Table 3 Comparison of Clinical Characteristics between Patients with and without Adverse Cardiovascular Events not Previously Known to have Diabetes Mellitus

From: Post-load hyperglycemia as an important predictor of long-term adverse cardiac events after acute myocardial infarction: a scientific study

 

Patientswith Cardiovascular Events

Patients without Cardiovascular Events

 
 

(n = 80 )

(n = 234)

p value

Basic characteristics

   

   Male, n (%)

59 (73.8)

182 (78.1)

0.44

   Age, year

64 ± 11

64 ± 10

0.91

   Body-mass index, kg/m2

23.5 ± 2.8

23.7 ± 2.8

0.71

   Family history of IHD, n (%)

26 (32.5)

68 (29.2)

0.58

   History of smoking, n (%)

58(72.5)

177 (76.0)

0.55

   Clinical history

   

Hypertension, n (%)

45 (56.3)

144 (61.8)

0.43

Hyperlipidemia, n (%)

52 (65.0)

137 (58.8)

0.36

Heart failure, n (%)

1 (1.3)

3 (1.3)

>0.99

Cerebrovascular disease, n (%)

4 (5.0)

14 (6.0)

>0.99

Chronic renal failure, n (%)

2 (2.5)

10 (4.3)

0.74

ASO, n (%)

6 (7.5)

9 (3.9)

0.22

Chronic obstructive pulmonary disease, n (%)

1 (1.3)

7 (3.0)

0.69

Malignancy, n (%)

5 (6.3)

12 (5.2)

0.78

   Previous procedures (PTCA/CABG), n (%)

6 (7.5)

10 (4.3)

0.25

Laboratory data at the time of admission

   

   Fasting blood sugar, mg/dL

95 ± 9

94 ± 10

0.45

   Blood sugar after 2 h, mg/dL

172 ± 51

160 ± 49

0.07

   HbA1c, %

5.4 ± 0.5

5.4 ± 0.4

0.75

   Total Cholesterol, mg/dL

198 ± 34

194 ± 38

0.34

   Triglyceride, mg/dL

109 ± 73

107 ± 71

0.85

   LDL-Cholesterol, mg/dL

134 ± 34

128 ± 34

0.18

   HDL-Cholesterol, mg/dL

42 ± 9

44 ± 15

0.16

   Serum creatinine, mg/dL

0.8 ± 0.2

0.8 ± 0.3

0.66

   Urea acid, mg/dL

5.4 ± 1.6

5.5 ± 1.5

0.75

Characteristics of acute myocardial infarction

   

   Systolic blood pressure on admission, mmHg

136 ± 26

138 ± 23

0.65

   Heart rate on admission, bpm/m

77 ± 18

73 ± 16

0.14

   Killip class≦‖, n (%)

7 (8.8)

11 (4.7)

0.26

   Anterior MI, n (%)

42 (52.5)

108 (46.4)

0.37

   Multi-vessel disease, n (%)

42 (52.5)

104 (44.6)

0.24

   Procedural features

   

Thrombolysis, n (%)

12 (15.0)

30 (12.9)

0.7

Primary PTCA/CABG, n (%)

47 (58.8)

158 (67.8)

0.17

Stent implantation, n (%)

63 (78.8)

178 (76.4)

0.75

   LVEF, %

42.2 ± 8.5

44.0 ± 8.2

0.11

   Peak CPK, U/L

2965 ± 1836

2857 ± 2154

0.71

Medications

   

   Aspirin, n (%)

79 (98.8)

227 (97.4)

0.68

   ACEI/ARB, n (%)

59 (73.8)

171 (73.4)

>0.99

   Beta-blockers, n (%)

53 (66.3)

125 (53.6)

0.07

   Statin, n (%)

37 (46.3)

112 (48.1)

0.8

   Oral hypoglycemic agents, n (%)

1 (1.3)

1 (0.4)

0.45

  1. IHD, ischemic heart disease; ASO, arteriosclerosis obliterans; PTCA, percutaneous transluminal coronary angioplasty; CABG, coronary artery bypass grafting; HbA1c, hemoglobin A1c; LDL-Cholesterol, low-density lipoprotein cholesterol; HDL-Cholesterol, high-density lipoprotein Cholesterol; MI, myocardial infarction; LVEF, left ventricular ejection fraction; CPK, creatine phosphokinase; ACEI, angiotensin-converting enzyme inhibitor; ARB, angiotensin II receptor blocker